Negareh Yazdani

Dr. Negareh Yazdani


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2021 in Ophthalmic and Physiological Optics
Verified
Journal Article
Closed access
PDF file
NYNegareh Yazdani
Negareh Yazdani
AEAsieh Ehsaei
Asieh Ehsaei
HHHosein Hoseini-Yazdi
Hosein Hoseini-Yazdi
NSNasser Shoeibi
Nasser Shoeibi
DADavid Alonso‐Caneiro
David Alonso‐Caneiro
MCMichael J Collins
Michael J Collins

18 August 2024 in Clinical and Experimental Optometry
Verified
Journal Article
Closed access
AMAli Abbasi Mehrabadi
Ali Abbasi Mehrabadi
JSJavad Sadeghi
Javad Sadeghi
NSNasser Shoeibi
Nasser Shoeibi
JSJavad Heravian Shandiz
Javad Heravian Shandiz
MSMehrdad Motamed Shariati
Mehrdad Motamed Shariati
NYNegareh Yazdani
Negareh Yazdani
Keratoconus has been known as a non-inflammatory, progressive ectatic disorder characterised by corneal thinning more prominently in the inferior zone.1 The prevalence of keratoconus is increasing ...

1 January 2025 in Parkinson's Disease
Verified
Journal Article
Open access
ZHZahra Hemmatian
Zahra Hemmatian
JSJavad Heravian Shandiz
Javad Heravian Shandiz
ASAli Shoeibi
Ali Shoeibi
NSNasser Shoeibi
Nasser Shoeibi
RSReyhane Shariati
Reyhane Shariati
NYNegareh Yazdani
Negareh Yazdani
Background: Previous studies revealed that optical coherence tomography (OCT) and visual evoked potential (VEP) were impaired in patients with Parkinson’s disease (PD), but the results were inconsistent; in this meta‐analysis, we tried to answer this issue by including studies that performed these two tests on the same sample size. Methods: PubMed, Scopus, Cochrane, and Google Scholar were comprehensively reviewed to retrieve the published studies investigating changes in OCT and VEP responses in PD patients. We analyzed the pooled weighted difference in means between PD patients and healthy controls using the random‐effects model. Results: Ten studies were included (12 sets of data), enrolling 337 PD patients and 273 healthy controls. The P100 latency in PD patients was significantly higher compared to healthy controls (difference in means = 6.16, 95% CI: 1.16–11.15, p = 0.02, n = 11). Significant thinning of the retinal nerve fiber layer (difference in means = −4.38, 95% CI: −6.29 to −2.47, p ≤ 0.001, n = 11) was observed in the PD eyes compared to the healthy subjects. However, no statistically significant difference was found in the means of P100 amplitude ( p = 0.06) and the average central foveal thickness ( p = 0.08) between PD patients and the control group. There was a significant negative correlation between RNFL weighted mean difference and P100 latency ( r = −0.65, p ≤ 0.001) in all subjects. Conclusions: Our results confirmed that Parkinson’s patients showed significant thinning of RNFL thickness and prolonged P100 latency time.

16 February 2026 in Journal of Ophthalmic and Vision Research
Verified
Journal Article
Open access
PDF file
AGAmir Golmakani
Amir Golmakani
NYNegareh Yazdani
Negareh Yazdani
Jamshid JamaliJamshid Jamali
Jamshid Jamali
AEAsieh Ehsaei
Asieh Ehsaei
Purpose: To investigate differences in corneal and ocular aberrations between hyperopic, emmetropic, and myopic eyes. Methods: This cross-sectional study included 84 eyes from 84 healthy participants (age range 18-35 years), who were equally divided into three refractive error groups of hyperopia, emmetropia, and myopia. Following comprehensive optometric examinations, corneal and ocular aberrations were measured using Pentacam and Zywave imaging systems, respectively. Aberrations were measured for a pupil diameter of 5 mm. Root-mean-square (RMS), Zernike coefficients, and compensation factor (CF) between total ocular and corneal aberrations were calculated for statistical analysis. Results: The mean spherical equivalent was +1.96 ± 1.64, –0.17 ± 0.19, and –2.46 ± 1.56 diopters in hyperopic (H), emmetropic (E), and myopic (M) eyes, respectively. The amount of corneal Zernike coefficients Z4–2 in the hyperopic eyes (H: 0.015 ± 0.040) was significantly higher than that of emmetropic eyes (E: –0.018 ± 0.054) and myopic eyes (M: –0.003 ± 0.038) with a P-value of 0.029. The RMS of corneal total coma (H: 0.228 ± 0.097, E: 0.183 ± 0.086, M: 0.164 ± 0.083, P-value: 0.009, respectively) and RMS of ocular fifth-order (H: 0.045 ± 0.018, E: 0.036 ± 0.020, M: 0.032 ± 0.016, P-value: 0.002) showed a significant difference between refractive error groups, with higher value in hyperopic eyes compared to the two other groups. There was no significant difference in CF for RMS and Zernike coefficients among the refractive error groups. Conclusion: Hyperopic eyes showed a higher RMS value for ocular fifth-order and corneal coma aberrations compared to the emmetropic and myopic eyes.